NEW YORK, April 25 - Incyte Genomics earned revenues of $51 million for the first quarter of 2001, up 25 percent from the same period a year ago, the company reported Wednesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.